All News

Researchers explored the benefits of tai chi and prevalence of liver disease in patients with osteoarthritis.

Research presented at American Heart Association’s 2024 Scientific Sessions examined the SGLT inhibitor’s effect on systolic blood pressure.

“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.

The Mediterranean diet is largely considered one of the healthiest diets.

James Rider, PharmD, shared reflections on his experiences as a pharmacy manager at CVS.

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

A collection of hospitals in Rochester, New York, have teamed up to create better access to prescription drugs and combat the city’s pharmacy desert issue.

Three research posters presented at the American Heart Association’s 2024 Scientific Sessions looked into the use of SGLT-2 inhibitors in patients with type 2 diabetes and cardiovascular complications.

Patients with type 2 diabetes who had eating problems and higher levels of diabetes distress had worse time-in-range.

Researchers aimed to determine the frequency of pain assessments and the extent of pain scores by age for patients undergoing traumatic surgery.

Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.

Adam J. James, PharmD, joined Drug Topics to discuss his career journey as a chain pharmacist.

Researchers evaluated the efficacy of a self-managed intervention vs enhanced usual care.

Michael Ganio, PharmD, BCPS, FASHP, discusses how the industry can become more resilient.

Researchers analyzed the impact of the COVID-19 pandemic on outcomes for patients with pancreatic cancer living in England.

Drug Topics sat down with Adam J. James, PharmD, to discuss his journey from chain pharmacist to innovation leader at Rite Aid."

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, also discusses ways community pharmacists can collaborate with other healthcare professionals to enhance diabetes management.

A conversation with Trent Thiede, PharmD, MBA, president of PAAS National, at NCPA 2024.

A conversation with Michael Ganio, PharmD, BCPS, FASHP, senior director of Pharmacy Practice and Quality at ASHP.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how pharmacists can help with diabetes prevention and early detection in the community.

Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.

A study found that a continuous glucose monitor workflow led by a pharmacist led to reduced HbA1c levels.

Cassandra Esperant, PharmD, AAHIVP, discussed the ups and downs of her career journey as a clinical HIV pharmacist.

A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.

Researchers compared the racial and ethnic representation of participants in food allergen trials with patients who experience food allergies.

Selina Coleman, JD, Partner in Life Sciences Health Industry Group at Reed Smith LLP, discussed recent developments in Supreme Court decisions impacting pharmacy operations.

The data from PURPOSE 2 will be published in The New England Journal of Medicine.

An FDA representative gave a presentation on her organization’s recent updates regarding drug supply chain rules and regulations.